ImThera Medical Inc Gets FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device
ImThera Medical, Inc., a privately held global medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its THN3 Clinical Study.
Read More